Covid-19 When to Give Remdesivir
Remdesivir is approved by the Food and Drug Administration (FDA) for the treatment of COVID-19 in hospitalised adult and paediatric patients (aged ≥12 years and weighing ≥40 kg). It is also available through an FDA Emergency Use Authorization (EUA) for the treatment of COVID-19 in hospitalised paediatric patients weighing 3.5 kg to <40 kg or […]
Covid-19 When to Give Remdesivir Read More »